Navigation Links
SuperNova Diagnostics® to Present at Biotech Showcase™ 2011 During J.P. Morgan Healthcare Conference January 10-13
Date:1/5/2011

WASHINGTON, LONDON and HONG KONG, Jan. 5, 2011 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, announced today that Neil J. Campbell, president and CEO, will present at Biotech Showcase 2011 in conjunction with the J.P. Morgan Healthcare Conference in San Francisco, CA.  

Mr. Campbell's presentation will be given at the Parc 55 Wyndham Hotel on Wednesday, January 12, 2011 at 3:30 p.m. PST.  "We are delighted to be presenting at a renowned conference such as Biotech Showcase," said Mr. Campbell.  "Biotech Showcase and the J.P. Morgan Healthcare Conference provide a unique opportunity to present to a diverse group of first-class investors and executives interested in medical and industrial diagnostics."

AmpCrystal®, SuperNova Diagnostics' lead technology and its multiple product formats, allows for minimally trained individuals (advanced CLIA-waived) to test for a wide range of protein analytes and can detect directly un-amplified DNA in humans, animals or environmental samples.  

Time-to-result has been shown in prototypes to be reduced to minutes on the spot versus the hours or days required when sending samples to a central laboratory or processing in regional satellite laboratories.  With three integrated capabilities (sample collector/processor, analytical disposable, and the readout device), the technology is simpler, more robust, faster and significantly less expensive than existing POC systems.

Significant advantages of AmpCrystals are direct detection of samples, simplification of product designs, ability to lower costs of delivery and broaden range of assay formats from the central laboratory.

About SuperNova Diagnostics®, Inc.SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can delivery novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® - Putting the Laboratory in the Palm of Your Hand®.

For additional information, please visit www.supernovadiagnostics.com.Media Contacts:Tiberend Strategic Advisors, Inc.(212) 827-0020Tamara Bright, tbright@tiberend.comorFarrell Denby, fdenby@tiberend.com
'/>"/>

SOURCE SuperNova Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
2. InterMune to Present at J.P. Morgan Healthcare Conference
3. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
4. Dendreon Announces Webcast Presentation at J.P. Morgan Healthcare Conference
5. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
6. PDL BioPharma to Present at the 29th Annual JP Morgan Healthcare Conference
7. VIVUS to Present at the 2011 JP Morgan Healthcare Conference
8. Jazz Pharmaceuticals to Present at the J.P. Morgan Healthcare Conference in San Francisco on January 12
9. HeartWare to Present at the 29th Annual J.P. Morgan Healthcare Conference
10. Pharmasset to Present at the 29th Annual J.P. Morgan Healthcare Conference
11. MAP Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/5/2017)... , June 5, 2017 Kohll,s Pharmacy ... the United States . The Raizer is ... a fallen person up to an almost-standing position ... and operated by one assistant and does not ... is simple enough that a child can operate it, ...
(Date:6/1/2017)... 2017 Nutriceutical Holdings (NH), parent company of ... and KD Pharma Group have decided to join forces ... Pharma Group. KD Pharma Group will become the largest ... the entire company. "We believe we have ... to growing the NH companies by providing us with ...
(Date:5/30/2017)... May 30, 2017 Therapix Biosciences Ltd. (Nasdaq: ... in the development of cannabinoid-based drugs, today announced ... overview at three upcoming scientific and investor conferences ... Micro Invitational: ... Date:                     Wednesday, ...
Breaking Medicine Technology:
(Date:6/28/2017)... , ... June 28, 2017 , ... ... is pleased to announce that a two year study conducted by the University ... Creek zeolite was successful in remediating potash brine-impacted groundwater. As a part of ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... ... protection assistance and financial consultations to communities in northern Virginia and DC, is ... to help provide for patients with Alzheimer’s and other disorders that lead to ...
(Date:6/27/2017)... ... June 27, 2017 , ... Nearly 70 percent of ... released today by the American Society for Dermatologic Surgery (ASDS). , ... of consumers considering a cosmetic medical procedure has doubled since 2013. , “Cosmetic ...
(Date:6/27/2017)... ... June 27, 2017 , ... Salucro, the ... the health care industry’s hospitals and provider groups, has announced that it will ... customers. Parasail Health is a San Francisco health-finance startup that has launched a ...
(Date:6/27/2017)... ... ... From June 20-22, EarQ and Widex held an exclusive training ... EarQ is headquartered. , Together, the organizations educate hearing care professionals on how ... the latest in hearing technology. At the event, EarQ members got an in-depth ...
Breaking Medicine News(10 mins):